https://youtu.be/XyaPOga4tAc The Future of Hemp in Oregon: A Call to Action with Courtney Moran In this important conversation, Justin Botillier, CEO of Calyx CPA

https://youtu.be/KUrstkJrHTw The Cannabis Journey Back to the Supreme Court: A Conversation with Katie Scates, CPA, JD Introducing Katie Scates and Her Unique Expertise Join Justin

https://youtu.be/uGd3jwHzwLE Navigating Oregon’s Certificate of Compliance Requirements for Cannabis Retailers In this informative video, Kevin Jacoby, owner of Jacoby Law, shares valuable insights into Oregon’shttps://youtu.be/uGd3jwHzwLE Navigating Oregon’s Certificate of Compliance Requirements for Cannabis Retailers In this informative video, Kevin Jacoby, owner of Jacoby Law, shares valuable insights into Oregon’s

When will Marijuana be rescheduled? Chat GPT’s Prediction! Author Chat GPT 06/21/2024 As we stand on the cusp of a historic shift in U.S. drug

We recently ran across an article written in May by Joseph A. Peterson, a Senior Attorney at Plunkett Cooney, called Beyond 280E: The Future of the Ordinary Business Deduction for Cannabis Businesses. His article again highlights how 280E has damaged the cannabis business and argues that companies have the constitutional right to claw back their lost deductions. See Justin’s video, which he recorded back in March.

The psychedelics industry has recently faced a significant setback as the U.S. Food and Drug Administration (FDA) denied Lykos Therapeutics’ approval request for MDMA-assisted therapy for PTSD. This decision has cast a shadow on the burgeoning field of psychedelic-assisted therapies, which has been gaining momentum over the past few years.

IRS Guidance on Section 471(c) and Section 280E: A Case of Strategic Silence In true IRS fashion, the memorandum recently brought to our attention explicitly

https://www.youtube.com/watch?v=gxTj5sT0hrg Taxation Challenges in the Psychedelic Industries At the recent PsyCon Convention in Las Vegas, Justin Botillier of Calyx CPA based in Medford, Oregon, delivered

Cannabis Rescheduling and the IRS’s Response to Business Deductions The recent decision by the Drug Enforcement Administration (DEA) to consider rescheduling marijuana under the

https://youtu.be/v6Qz65DQA1I Insights on Amending Returns and Navigating Legal Changes Join Justin Botillier and Jamie Jorgenstone as they delve into the complexities of amending tax returns

California’s Pioneering Legislation for Psychedelic Therapy In an era where mental health innovation is more crucial than ever, California stands at the forefront of a

Justin Botillier, the CEO of Calyx CPA in Medford, Oregon, shares his insights and personal journey within the cannabis industry. His commitment to cannabis legalization